Prophylactic use of a beta-blocker to reduce postoperative cardiac events is an important advancement in the field of perioperative medicine. Perioperative use of a beta-blocker to prevent surgical cardiovascular morbidity and mortality is baed on physiologic principles and supported by empirical evidence. It is a relatively simple and low-cost strategy.
|Translated title of the contribution||Using beta-blocker to cut perioperative risk in CAD|
|Number of pages||4|
|State||Published - Dec 1 2006|
ASJC Scopus subject areas